636 related articles for article (PubMed ID: 2471770)
21. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
Misko IS; Sculley TB; Schmidt C; Moss DJ; Soszynski T; Burman K
Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323
[TBL] [Abstract][Full Text] [Related]
22. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
Anichini A; Maccalli C; Mortarini R; Salvi S; Mazzocchi A; Squarcina P; Herlyn M; Parmiani G
J Exp Med; 1993 Apr; 177(4):989-98. PubMed ID: 8459226
[TBL] [Abstract][Full Text] [Related]
23. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
[TBL] [Abstract][Full Text] [Related]
24. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
25. Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.
Kan-Mitchell J; Liggett PE; Harel W; Steinman L; Nitta T; Oksenberg JR; Posner MR; Mitchell MS
Cancer Immunol Immunother; 1991; 33(5):333-40. PubMed ID: 1831067
[TBL] [Abstract][Full Text] [Related]
26. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
[TBL] [Abstract][Full Text] [Related]
27. Immunoregulatory effects of CD4+ T helper subsets in human melanoma.
Lee KY; Goedegebuure PS; Linehan DC; Eberlein TJ
Surgery; 1995 Apr; 117(4):365-72. PubMed ID: 7716716
[TBL] [Abstract][Full Text] [Related]
28. Generation of Melan-A/MART-1-specific CD8+ cytotoxic T lymphocytes from human naive precursors: helper effect requirement for efficient primary cytotoxic T lymphocyte induction in vitro.
Ostankovitch M; Le Gal FA; Connan F; Chassin D; Choppin J; Guillet JG
Int J Cancer; 1997 Sep; 72(6):987-94. PubMed ID: 9378563
[TBL] [Abstract][Full Text] [Related]
29. MHC-restricted responses of CD8+ and CD4+ T-cell clones from regional lymph nodes of melanoma patients.
Chen Q; Hersey P
Int J Cancer; 1992 May; 51(2):218-24. PubMed ID: 1568790
[TBL] [Abstract][Full Text] [Related]
30. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
[TBL] [Abstract][Full Text] [Related]
31. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.
Knuth A; Wölfel T; Klehmann E; Boon T; Meyer zum Büschenfelde KH
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2804-8. PubMed ID: 2784858
[TBL] [Abstract][Full Text] [Related]
32. HLA-B-restricted, CD8+ cytolytic human T cell clones derived from a melanoma-invaded lymph node.
Nakashima M; Watanabe T; Koprowski H; Steplewski Z
Hybridoma; 1996 Apr; 15(2):147-54. PubMed ID: 8743295
[TBL] [Abstract][Full Text] [Related]
33. Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus.
Yasukawa M; Inatsuki A; Kobayashi Y
J Immunol; 1988 May; 140(10):3419-25. PubMed ID: 2452188
[TBL] [Abstract][Full Text] [Related]
34. Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures.
Hersey P; MacDonald M; Schibeci S; Burns C
Cancer Immunol Immunother; 1986; 22(1):15-23. PubMed ID: 2423240
[TBL] [Abstract][Full Text] [Related]
35. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
Koide J; Engleman EG
J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
[TBL] [Abstract][Full Text] [Related]
36. Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4.
Paliard X; Yssel H; Blanchard D; Waitz JA; deVries JE; Spits H
J Immunol; 1989 Jul; 143(2):452-7. PubMed ID: 2472439
[TBL] [Abstract][Full Text] [Related]
37. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
Darrow TL; Slingluff CL; Seigler HF
J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A.
Hayashi Y; Hoon DS; Park MS; Terasaki PI; Morton DL
Cancer Immunol Immunother; 1992; 34(6):419-23. PubMed ID: 1373343
[TBL] [Abstract][Full Text] [Related]
39. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
40. Human autologous tumor-specific T cells in malignant melanoma.
Platsoucas CD
Cancer Metastasis Rev; 1991 Jun; 10(2):151-76. PubMed ID: 1873855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
